Acesso livre
Acesso livre

Endocrinologia

Perspectiva | Provedores da atenção primária devem prescrever aspirina para evitar doença cardiovascular com base na relação risco–benefício, e não na idade.

20 Jan, 2022 | 19:38h

Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age – Family Medicine and Community Health

Comentários:

Researchers urge: ‘Prescribe aspirin based on benefit-to-risk not age’ – Florida Atlantic University

Preventive Aspirin Should Be Based on Benefit, Not Age – HealthDay

Conteúdo relacionado: USPSTF draft statement revises previous guidance and now recommends against initiating low-dose aspirin use for the primary prevention of CVD in adults aged 60 years or older.

Avaliação e tratamento de distúrbios da tireoide na gestação e no pós-parto.

20 Jan, 2022 | 16:09h

Assessment and treatment of thyroid disorders in pregnancy and the postpartum period – Nature Reviews Endocrinology (se o acesso a este link for pago, tente este)

 

Comentário no Twitter

 

Estudo randomizado | Em pacientes com acromegalia que já toleraram e responderam tanto à octreotida oral quanto aos ligantes injetáveis do receptor de somatostatina, a primeira foi não inferior à segunda em manter a resposta bioquímica e controlar os sintomas.

17 Jan, 2022 | 12:40h

Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial – The Lancet Diabetes & Endocrinology (link para o resumo – $ para o texto completo)

O ano de 2021 na medicina cardiovascular: diabetes e doenças metabólicas.

13 Jan, 2022 | 20:59h

The year in cardiovascular medicine 2021: diabetes and metabolic disorders – European Heart Journal

O ano de 2021 na medicina cardiovascular: dislipidemia.

13 Jan, 2022 | 20:57h

The year in cardiovascular medicine 2021: dyslipidemia – European Heart Journal

M-A | Jejum intermitente e desfechos de saúde relacionados à obesidade.

13 Jan, 2022 | 20:52h

Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials – JAMA Network Open

Estudo randomizado | Semaglutida semanal em alta dose (2,4 mg) resultou em aumento na perda de peso em comparação com liraglutida diária (3 mg).

13 Jan, 2022 | 11:59h

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial – JAMA (gratuito por tempo limitado)

 

Comentário no Twitter

 

Estudo de coorte | Alto consumo de azeite de oliva está associado a menor risco de mortalidade cardiovascular, por câncer e por todas as causas.

13 Jan, 2022 | 11:43h

Consumption of Olive Oil and Risk of Total and Cause-Specific Mortality Among U.S. Adults – Journal of the American College of Cardiology (link para o resumo – $ para o texto completo)

Comentários:

Higher olive oil intake associated with lower risk of CVD mortality – American College of Cardiology

Higher Olive Oil Intake May Be Associated With Lower Risk of CVD Mortality – American College of Cardiology

Diretriz científica AHA | Tratamento abrangente dos fatores de risco cardiovascular para adultos com diabetes tipo 2.

12 Jan, 2022 | 12:56h

Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association – Circulation

Comunicado de imprensa: Fewer than 1 in 5 adults with Type 2 diabetes in the U.S. are meeting optimal heart health targets – American Heart Association

Diretriz da ADA 2022 para o cuidado médico no diabetes.

10 Jan, 2022 | 12:27h

Página principal da diretriz: ADA 2022 Standards of Medical Care in Diabetes – American Diabetes Association

Introdução: Standards of Medical Care in Diabetes—2022

Resumo das revisões: Standards of Medical Care in Diabetes—2022

Standards of Medical Care in Diabetes—2022 Guideline Abridged for Primary Care Providers

Resumo em vídeo: Standards of Care in Diabetes – 2022

  1. Improving Care and Promoting Health in Populations
  2. Classification and Diagnosis of Diabetes 
  3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities
  4. Comprehensive Medical Evaluation and Assessment of Comorbidities
  5. Facilitating Behavior Change and Well-being to Improve Health Outcomes
  6. Glycemic Targets
  7. Diabetes Technology
  8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes
  9. Pharmacologic Approaches to Glycemic Treatment
  10. Cardiovascular Disease and Risk Management
  11. Chronic Kidney Disease and Risk Management
  12. Retinopathy, Neuropathy, and Foot Care
  13. Older Adults
  14. Children and Adolescents
  15. Management of Diabetes in Pregnancy
  16. Diabetes Care in the Hospital
  17. Diabetes Advocacy

 

Comentários no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.